2-[4-[[(3S,5R)-5-[1-(4-methylpiperazin-1-yl)ethenyl]pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-piperidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-pyrrolidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol

C74H86N16O3 — CID 159502419

IUPAC2-[4-[[(3S,5R)-5-[1-(4-methylpiperazin-1-yl)ethenyl]pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-piperidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-pyrrolidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol
SMILESC=C([C@H]1C[C@H](Nc2nc(-c3ccccc3O)nc3ccccc23)CN1)N1CCCC1.C=C([C@H]1C[C@H](Nc2nc(-c3ccccc3O)nc3ccccc23)CN1)N1CCCCC1.C=C([C@H]1C[C@H](Nc2nc(-c3ccccc3O)nc3ccccc23)CN1)N1CCN(C)CC1
InChIInChI=1S/C25H30N6O.C25H29N5O.C24H27N5O/c1-17(31-13-11-30(2)12-14-31)22-15-18(16-26-22)27-24-19-7-3-5-9-21(19)28-25(29-24)20-8-4-6-10-23(20)32;1-17(30-13-7-2-8-14-30)22-15-18(16-26-22)27-24-19-9-3-5-11-21(19)28-25(29-24)20-10-4-6-12-23(20)31;1-16(29-12-6-7-13-29)21-14-17(15-25-21)26-23-18-8-2-4-10-20(18)27-24(28-23)19-9-3-5-11-22(19)30/h3-10,18,22,26,32H,1,11-16H2,2H3,(H,27,28,29);3-6,9-12,18,22,26,31H,1-2,7-8,13-16H2,(H,27,28,29);2-5,8-11,17,21,25,30H,1,6-7,12-15H2,(H,26,27,28)/t2*18-,22+;17-,21+/m000/s1
InChIKeyLZOCQPRDBXPRSB-CZNDLINKSA-N
MW1247.61 g/mol
LogP10.80
Rot. Bonds15

About 2-[4-[[(3S,5R)-5-[1-(4-methylpiperazin-1-yl)ethenyl]pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-piperidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-pyrrolidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol

2-[4-[[(3S,5R)-5-[1-(4-methylpiperazin-1-yl)ethenyl]pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-piperidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-pyrrolidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol (PubChem CID 159502419) has the molecular formula C74H86N16O3 and a molecular weight of 1247.61 g/mol. Its IUPAC name is 2-[4-[[(3S,5R)-5-[1-(4-methylpiperazin-1-yl)ethenyl]pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-piperidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-pyrrolidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol.

Molecular Properties

Compound Name2-[4-[[(3S,5R)-5-[1-(4-methylpiperazin-1-yl)ethenyl]pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-piperidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-pyrrolidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol
PubChem CID159502419
Molecular FormulaC74H86N16O3
Molecular Weight1247.61 g/mol
Exact Mass1246.71
IUPAC Name2-[4-[[(3S,5R)-5-[1-(4-methylpiperazin-1-yl)ethenyl]pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-piperidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-pyrrolidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol
SMILESC=C([C@H]1C[C@H](Nc2nc(-c3ccccc3O)nc3ccccc23)CN1)N1CCCC1.C=C([C@H]1C[C@H](Nc2nc(-c3ccccc3O)nc3ccccc23)CN1)N1CCCCC1.C=C([C@H]1C[C@H](Nc2nc(-c3ccccc3O)nc3ccccc23)CN1)N1CCN(C)CC1
InChIInChI=1S/C25H30N6O.C25H29N5O.C24H27N5O/c1-17(31-13-11-30(2)12-14-31)22-15-18(16-26-22)27-24-19-7-3-5-9-21(19)28-25(29-24)20-8-4-6-10-23(20)32;1-17(30-13-7-2-8-14-30)22-15-18(16-26-22)27-24-19-9-3-5-11-21(19)28-25(29-24)20-10-4-6-12-23(20)31;1-16(29-12-6-7-13-29)21-14-17(15-25-21)26-23-18-8-2-4-10-20(18)27-24(28-23)19-9-3-5-11-22(19)30/h3-10,18,22,26,32H,1,11-16H2,2H3,(H,27,28,29);3-6,9-12,18,22,26,31H,1-2,7-8,13-16H2,(H,27,28,29);2-5,8-11,17,21,25,30H,1,6-7,12-15H2,(H,26,27,28)/t2*18-,22+;17-,21+/m000/s1
InChIKeyLZOCQPRDBXPRSB-CZNDLINKSA-N
XLogP10.80
TPSA223.17 Ų
H-Bond Donors9
H-Bond Acceptors19
Rotatable Bonds15
Heavy Atoms93
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001247.61
LogP ≤ 510.80
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1019

Analyze 2-[4-[[(3S,5R)-5-[1-(4-methylpiperazin-1-yl)ethenyl]pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-piperidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-pyrrolidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[4-[[(3S,5R)-5-[1-(4-methylpiperazin-1-yl)ethenyl]pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-piperidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-pyrrolidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol?
The IUPAC name of 2-[4-[[(3S,5R)-5-[1-(4-methylpiperazin-1-yl)ethenyl]pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-piperidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-pyrrolidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol (CID 159502419) is 2-[4-[[(3S,5R)-5-[1-(4-methylpiperazin-1-yl)ethenyl]pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-piperidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-pyrrolidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol.
What is the SMILES notation for 2-[4-[[(3S,5R)-5-[1-(4-methylpiperazin-1-yl)ethenyl]pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-piperidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-pyrrolidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol?
The canonical SMILES for 2-[4-[[(3S,5R)-5-[1-(4-methylpiperazin-1-yl)ethenyl]pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-piperidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-pyrrolidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol is C=C([C@H]1C[C@H](Nc2nc(-c3ccccc3O)nc3ccccc23)CN1)N1CCCC1.C=C([C@H]1C[C@H](Nc2nc(-c3ccccc3O)nc3ccccc23)CN1)N1CCCCC1.C=C([C@H]1C[C@H](Nc2nc(-c3ccccc3O)nc3ccccc23)CN1)N1CCN(C)CC1.
What is the InChIKey of 2-[4-[[(3S,5R)-5-[1-(4-methylpiperazin-1-yl)ethenyl]pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-piperidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-pyrrolidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol?
The InChIKey is LZOCQPRDBXPRSB-CZNDLINKSA-N. The full InChI is InChI=1S/C25H30N6O.C25H29N5O.C24H27N5O/c1-17(31-13-11-30(2)12-14-31)22-15-18(16-26-22)27-24-19-7-3-5-9-21(19)28-25(29-24)20-8-4-6-10-23(20)32;1-17(30-13-7-2-8-14-30)22-15-18(16-26-22)27-24-19-9-3-5-11-21(19)28-25(29-24)20-10-4-6-12-23(20)31;1-16(29-12-6-7-13-29)21-14-17(15-25-21)26-23-18-8-2-4-10-20(18)27-24(28-23)19-9-3-5-11-22(19)30/h3-10,18,22,26,32H,1,11-16H2,2H3,(H,27,28,29);3-6,9-12,18,22,26,31H,1-2,7-8,13-16H2,(H,27,28,29);2-5,8-11,17,21,25,30H,1,6-7,12-15H2,(H,26,27,28)/t2*18-,22+;17-,21+/m000/s1.
What are the key properties of 2-[4-[[(3S,5R)-5-[1-(4-methylpiperazin-1-yl)ethenyl]pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-piperidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-pyrrolidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol?
2-[4-[[(3S,5R)-5-[1-(4-methylpiperazin-1-yl)ethenyl]pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-piperidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-pyrrolidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol has a molecular weight of 1247.61 g/mol, XLogP of 10.80, 15 rotatable bonds, 9 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-[[(3S,5R)-5-[1-(4-methylpiperazin-1-yl)ethenyl]pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-piperidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol;2-[4-[[(3S,5R)-5-(1-pyrrolidin-1-ylethenyl)pyrrolidin-3-yl]amino]quinazolin-2-yl]phenol is sourced from PubChem (CID 159502419), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).